4//SEC Filing
Brockstedt Dirk G. 4
Accession 0001593968-22-000454
CIK 0001673772other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 3:09 PM ET
Size
8.4 KB
Accession
0001593968-22-000454
Insider Transaction Report
Form 4
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Common Stock
2022-02-11$6.18/sh+2,647$16,358→ 22,459 total - Sale
Common Stock
2022-02-11$22.47/sh−2,647$59,478→ 19,812 total - Exercise/Conversion
Option (right to buy)
2022-02-11−2,647→ 19,695 totalExercise: $6.18Exp: 2028-03-27→ Common Stock (2,647 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001635616
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 3:09 PM ET
- Size
- 8.4 KB